A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department
- PMID: 18021045
- DOI: 10.5694/j.1326-5377.2007.tb01418.x
A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department
Abstract
Objective: To assess efficacy and safety of a 24-hour comprehensive protocol-driven model for rapid assessment and thrombolysis of stroke patients in the emergency department.
Design: Prospective open observational study.
Participants and setting: All patients with acute stroke presenting within 3 hours to the St Vincent's Hospital (Sydney) emergency department between 1 December 2004 and 30 July 2005.
Main outcome measures: Proportion of patients treated, patient demographics, clinical outcome, adverse events and time to treatment parameters.
Results: 134 patients (100 stroke; 34 transient ischaemic attack) were admitted to the stroke unit during the study period. Of the 100 stroke patients, 40 presented within 3 hours of symptom onset. Fifteen patients had no contraindications and received intravenous thrombolysis. At 3 months, 10 patients (67%) were independent (modified Rankin score [mRS], 0-2) and seven (47%) had an excellent functional outcome (mRS < or = 1). Symptomatic intracranial haemorrhage was not observed. The median time from symptom onset to tissue plasminogen activator treatment was 155 minutes (range, 105-197 min). Median onset-to-door, door-to-computed tomography, and door-to-needle times were 48, 25, and 87 minutes, respectively.
Conclusion: Rapid assessment of stroke in the emergency department according to a comprehensive protocol allows identification and treatment of acute ischaemic stroke patients eligible for thrombolysis.
Comment in
-
Tissue plasminogen activator for acute ischaemic stroke.Med J Aust. 2008 Apr 21;188(8):488; author reply 489-90. doi: 10.5694/j.1326-5377.2008.tb01729.x. Med J Aust. 2008. PMID: 18429722 No abstract available.
-
Tissue plasminogen activator for acute ischaemic stroke.Med J Aust. 2008 Apr 21;188(8):489; author reply 489-90. doi: 10.5694/j.1326-5377.2008.tb01730.x. Med J Aust. 2008. PMID: 18429726 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
